Skip to content
AnalystLens
Back to MRNAIncome Statement

Moderna, Inc. EPS (Basic) 2016-2026 | MRNA

Annual FY2016–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

−$7.26

+21.8%YoY vs FY2024Source: 10-KFY2025

From −$3.79 in FY2016 to −$7.26 in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26−$3.40−34.9%Not reportedNot reportedNot reported
FY25−$2.52+17.9%−$2.13+36.0%−$0.51−1800.0%Not reported
FY24−$3.07−1635.0%−$3.33+8.0%$0.03+100.3%Not reported
FY23$0.20−97.8%−$3.62−165.2%−$9.53−456.9%Not reported
FY22$9.09+198.0%$5.55−19.9%$2.67−67.7%Not reported

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionGrowing
CAGR

N/A

FY2020
−$1.96
FY2025
−$7.26

5 years selected · on the chart

EPS (Basic) History

Year-over-year comparison from 10-K annual reports

  1. −$7.26
YoY changeLargest recent move+68.7%in FY19Latest +21.8%

2 older moves run past ±150% (largest +1646.4%); point at, tap or drag across the bars to read one.

EPS (Basic), period by period

PeriodValueChangeSource
FY2025−$7.26+21.8%10-K
FY2024−$9.28+24.7%10-K
FY2023−$12.33−158.0%10-K
FY2022$21.26−29.9%10-K
FY2021$30.31+1646.4%10-K
FY2020−$1.96−26.5%10-K
FY2019−$1.55+68.7%10-K
FY2018−$4.95−18.4%10-K
FY2017−$4.18−10.3%10-K
FY2016−$3.79—10-K

What is eps (basic)?

Basic earnings per share (EPS) can be defined as net income divided by the weighted average number of common shares outstanding during a period.

What is Moderna, Inc.'s current eps (basic)?

Moderna, Inc. (MRNA) annual eps (basic) for 2025 was $-7.26, a 21.77% increase from 2024. Moderna, Inc. eps (basic) for the quarter ending March 31, 2026 was $-3.40.

What was Moderna, Inc.'s eps (basic) in 2024?

Moderna, Inc. annual eps (basic) for 2024 was $-9.28, a 24.74% increase from 2023.

What was Moderna, Inc.'s eps (basic) in 2023?

Moderna, Inc. annual eps (basic) for 2023 was $-12.33, a 158.00% decline from 2022.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)